News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
162 Results
Type
Article (2)
Press Release (160)
Section
Business (61)
Deals (11)
Drug Development (9)
FDA (1)
News (78)
Policy (3)
Tag
Alliances (20)
Approvals (1)
Artificial intelligence (2)
Cancer (1)
Clinical research (2)
Collaboration (1)
COVID-19 (2)
Diabetes (1)
Diagnostics (1)
Drug discovery (1)
Earnings (33)
Events (29)
Executive appointments (1)
FDA (2)
Funding (1)
GLP-1 (1)
Government (1)
Healthcare (16)
Infectious disease (2)
IPO (9)
Machine learning (1)
Mergers & acquisitions (4)
Metabolic disorders (1)
People (14)
Phase I (2)
Phase II (2)
Phase III (1)
Preclinical (8)
Regulatory (2)
Date
Last 30 days (2)
Last 365 days (26)
2025 (12)
2024 (20)
2023 (24)
2022 (27)
2021 (34)
2020 (34)
2019 (3)
2018 (4)
2017 (4)
Location
Asia (2)
Canada (17)
China (1)
Europe (6)
Texas (11)
United States (12)
Utah (1)
162 Results for "immunoprecise".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ImmunoPrecise Antibodies Announces Key Leadership Changes
February 24, 2025
·
6 min read
Press Releases
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA’s Shift to Non-Animal Testing Methods
April 11, 2025
·
4 min read
Press Releases
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025
March 28, 2025
·
13 min read
Press Releases
ImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance Period
February 20, 2025
·
1 min read
Business
ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer
ImmunoPrecise Antibodies Ltd. is pleased to announce the appointment of Kristin Taylor as Chief Financial Officer, effective immediately.
June 27, 2024
·
3 min read
Press Releases
ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.
March 13, 2025
·
4 min read
Press Releases
ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation
January 17, 2025
·
4 min read
Press Releases
ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases
December 23, 2024
·
4 min read
Press Releases
ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture
January 27, 2025
·
4 min read
Press Releases
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
November 5, 2024
·
5 min read
1 of 17
Next
